JAK2 and systemic sclerosis: Analysis of the expression of TLR7, TLR9 and JAK2 in PBMC samples from 50 SSc patients and 13 healthy individuals revealed significant TLR7 upregulation in the SSc patients and decreased levels of TLR9 and JAK2.